Hangzhou Artery Technology Co., Ltd.
PrivateLast Round
IPO
Jan 29, 2026
Company Overview
Hangzhou Artery Technology Co., Ltd. is a medical technology company that specializes in high-performance computing for medical imaging and AI-driven diagnostic solutions for cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Artery Technology Co., Ltd. Comparables
Compare Hangzhou Artery Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raysight Medical | 87% | |
| Shukun Technology | 86% | |
| Shanghai United Imaging Healthcare | 84% | |
Hangzhou Artery Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 29, 2026 |
Hangzhou Artery Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou Artery Technology Co., Ltd.'s valuation, stock price, and market status.